Evidence map›Paper›PMID 37428341›Full record

SynthesisCurrent nutrition reports2023

Effects of Withania somnifera (Ashwagandha) on Hematological and Biochemical Markers, Hormonal Behavior, and Oxidant Response in Healthy Adults: A Systematic Review.

Adrián Gómez Afonso, Diego Fernandez-Lazaro, David P Adams, Aniol Monserdà-Vilaró, Cesar I Fernandez-Lazaro

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Current nutrition reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Effects ofNutrients · 2026
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Plant Part-Specific Differences in Ashwagandha (Food science & nutrition · 2026
    Review
  7. Article
  8. Ageing in Unani medicine: Conceptual framework and modulatory approaches.Journal of Ayurveda and integrative medicine · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Nutraceutical Applications ofFoods (Basel, Switzerland) · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Adrián Gómez Afonso *Faculty of Physical Activity Sport Sciences, European University of Madrid, 28670, Madrid, Spain.
Diego Fernandez-Lazaro *Departamento de Biología Celular, Genética, Histología y Farmacología, Facultad de Ciencias de la Salud, Campus de Soria, Universidad de Valladolid, Soria, 42004, Spain. diego.fernandez.lazaro@uva.es.
David P AdamsUniversity of Galway, University Road, Galway, H91 TK33, Ireland.
Aniol Monserdà-VilaróFaculty of Physical Activity Sport Sciences, European University of Madrid, 28670, Madrid, Spain.
Cesar I Fernandez-LazaroDepartment of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008, Pamplona, Spain. fernandezlazaro@usal.es.ORCID 0000-0003-2366-2528
Universidad Europea de Madrid · ESNavarre Institute of Health Research · ESOllscoil na Gaillimhe – University of Galway · IEUniversidad de Valladolid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PURPOSE OF REVIEW: Withania somnifera (L.) Dunal (Ws) is a common herb plant that has been used for centuries to treat a wide range of conditions, particularly certain chronic diseases due to its antidiabetic, cardioprotective, antistress, and chondroprotective effects, among many others. No conclusive evidence, however, exists about the potential health effects of Ws in adults without chronic conditions. We aimed to evaluate the current evidence on the health benefits of Ws supplementation in healthy adults. RECENT

findingsBased on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically reviewed studies indexed in Web of Science, Scopus, and PubMed to assess the effects of Ws on hematological and biochemical markers, hormonal behavior, and oxidant response in healthy adults. Original articles published up to March 5, 2022, with a controlled trial design or pre-post intervention design, in which supplementation of Ws was compared to a control group or data prior to intervention were included. Among 2,421 records identified in the search, 10 studies met the inclusion criteria. Overall, most of the studies reported beneficial effects of the Ws supplementation, and no serious adverse events were reported. Participants supplemented with Ws displayed reduced levels of oxidative stress and inflammation, and counterbalanced hormone levels. No evidence of the beneficial effects of Ws supplementation on hematological markers was reported. Ws supplementation appears to be safe, may regulate hormone levels, and has potent anti-inflammatory and antioxidant effects. However, further studies are needed to elucidate the relevance of its application.

Indexed as

WithaniaAdultBiomarkersHormonesHumansOxidantsPlant ExtractsAshwagandhaBiomarkersHormonesOxidantsPlant ExtractsAshwagandhaBiomarkersHealthy adultsPlant supplementSystematic reviewWithania somnifera

Identifiers

PMID37428341
PMCPMC10444651
OpenAlexW4383710814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.